ARTICLE | Clinical News
Clonicel clonidine regulatory update
October 5, 2009 7:00 AM UTC
Addrenex submitted an sNDA to FDA for Clonicel clonidine to treat attention-deficit hyperactivity disorder (ADHD). Clonicel is a modified-release formulation of clonidine, an adrenergic receptor alph...